IAS Statin Newsletter

The Lorenzini Medical Foundation is the administrative and organizational partner of the International Atherosclerosis Society, and manages all the affairs of this prestigious organization, including its 67 member societies with its more than 18,000 members in 57 different countries worldwide.

The mission of the IAS which closely overlaps that of the Foundation is to coordinate the exchange of scientific information among the constituent societies, to foster research into the development of atherosclerosis, and to help translate this knowledge into improving the effectiveness of programs designed to prevent and treat this disease, and its related Cardiometabolic disorders and Cerebrovascular diseases.

The IAS endeavors to achieve these objectives by

  • promoting the exchange of existing knowledge and research;
  • encouraging and supporting funding for new research ventures and interdisciplinary approaches;
  • establishing visiting fellowships for young investigators and providing educational opportunities for younger researchers and healthcare professionals;
  • fostering the dissemination of knowledge by organizing international symposia, workshops, courses, meetings;
  • maintaining an effective website;
  • interacting with other organizations with similar objectives.

The programs are realized through collaborative efforts of the IAS with its national and regional constituent societies.

The IAS is in a growth phase and now aims to expand its activities to other areas that will achieve a broader agenda, such as new approaches to guideline development and increasing the awareness and the exchange of ideas and data to improve access to care for patients with FH and severe lipoprotein disorders.

The IAS is able to promote its mission and objectives from a more international perspective than other organizations due to its unique position throughout the world as a federation of many regional and national members, including new and emerging countries with substantively different cultures, environments, genetics, and diseases and is thus able to open the field to new ideas and interpretations from both developed and lesser-developed areas of the world. Concepts, medicine, and people are able to bridge in both directions, to enrich the world.